http://www.investorideas.com/news/2013/NASDAQ/07051.asp
New York, NY - July 5, 2013 (www.investorideas.com newswire) Investorideas.com, an investor research portal specializing in sector research for independent investors, including biotech stocks issues a trading alert for NASDAQ’s top gainer, Prima Biomed Ltd. (NASDAQ: PBMD), trading up at $2.60, gaining 0.38 or 17.12% as of 2:22PM EDT on light volume of 51,000 shares.
The company reported on Wednesday after the market close, that it has activated a substantial number of additional clinical trial sites in Belgium, Bulgaria, Germany, Lithuania, and Latvia. CANVAS is a phase 2/3 study of CVac™ for the maintenance treatment of newly diagnosed, late-stage epithelial ovarian cancer patients who achieve remission after optimal debulking surgery and standard first line chemotherapy.
This expansion in Europe doubles the number of actively recruiting clinical trial sites for the trial, which has been ongoing at sites in Australia, Belarus, Ukraine, and the United States.
wakey wakey mr market, page-135
-
- There are more pages in this discussion • 269 more messages in this thread...
This thread is closed.
You may not reply to this discussion at this time.
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
0.005(1.72%) |
Mkt cap ! $428.5M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 29.8¢ | 29.0¢ | $280.6K | 954.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 38 | 246743 | 29.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.5¢ | 240428 | 15 |
View Market Depth
| Last trade - 12.50pm 11/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |